Edenred Shares Rise 7% in a Week Despite Citi Lowering Target to €19

Recent Price Target Adjustment by Citi

The day before, Citi revised its price target for Edenred downward from €20.00 to €19.00, while maintaining a 'hold' recommendation. This adjustment places the target nearly at the current price level of €19.03, suggesting almost no upside potential according to the American bank. Over the year, the stock is still down 38.21%, indicating a prolonged correction that has significantly eroded the valuation of the employee benefits specialist. Pluxee, its direct competitor emerging from the spin-off of Sodexo, meanwhile, recorded a rise of 1.24% this Wednesday during the session, in a comparable but more moderate movement. The upcoming financial calendar could be a catalyst: the publication of quarterly revenue on April 23, followed by the general meeting scheduled for May 7, will provide operators with concrete elements to assess the group's commercial trajectory at the start of this fiscal year.

Technical Analysis Overview

From a technical standpoint, Edenred's share price is above its 50-day moving average (€18.11) and its 20-day moving average (€17.67), indicating a short-term bullish momentum. However, the stock remains well below its 200-day moving average, set at €20.99, signaling that the underlying trend remains fragile. The Bollinger Bands suggest caution. The price is at 86% of the amplitude between the lower bound (€15.78) and the upper bound (€19.57), a potential overbought zone that could hinder progress if the stock fails to break through the resistance identified at €19.74. The RSI, at 58, confirms this reading: the momentum is positive but not excessive, leaving a narrow margin before reaching the conventional overbought threshold of 70.